Thomas Engstrom
Clinical trials sponsored by Thomas Engstrom, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart attack procedures aim to save more lives and prevent repeat attacks Results expected Feb 2027 (estimated)
-
Ambulance steroid shot may cut heart attack deaths, large trial underway
Disease control Recruiting nowThis phase 3 trial tests whether a single high dose of the steroid methylprednisolone, given in the ambulance before opening the blocked artery, can reduce deaths in people having a major heart attack (STEMI). About 5,200 adults will be randomly assigned to receive either the ste…
Phase 3 • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New heart attack procedures aim to save more lives and prevent repeat attacks
Disease control Recruiting nowThis study tests two methods used during emergency heart attack treatment: ischemic postconditioning (briefly pausing blood flow after opening the artery) and ultrasound-guided stent placement. The goal is to see if these techniques reduce death, heart failure, or the need for an…
Sponsor: Thomas Engstrom • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC